Infection is an Independent Predictor of Death in Diffuse Large B Cell Lymphoma

QR Code

Infection is an Independent Predictor of Death in Diffuse Large B Cell Lymphoma

Abstract To identify risk factors for infection in patients with diffuse large B cell lymphoma (DLBCL) undergoing rituximab, cyclophosphamide, vincristine, adriamycin and prednisolone (R-CHOP) treatment. All patients with DLBCL who received R-CHOP from 2004–2014 in a tertiary Australian hospital wer...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Claire Dendle, Michael Gilbertson, Tim Spelman, Rhonda L. Stuart, Tony M. Korman, Karin Thursky, Stephen Opat, Zoe McQuilten
Format:	article
Langue:	EN
Publié:	Nature Portfolio 2017
Sujets:	Medicine R Science Q
Accès en ligne:	https://doaj.org/article/8a6a1943b81149ab8bde5882ee1cadd6
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Patient-Specific Modeling of Diffuse Large B-Cell Lymphoma
par: Kirsten Thobe, et autres
Publié: (2021)

Immune targeted therapy for diffuse large B cell lymphoma
par: Yaxin Zheng, et autres
Publié: (2021)

TREATMENT OF RELAPSED, REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA
par: Ebru Pekgüç, et autres
Publié: (2021)

Epstein-Barr Virus-Positive Adrenal Diffuse Large B-Cell Lymphoma after Treatment for Angioimmunoblastic T-Cell Lymphoma
par: Akiko Hashimoto, et autres
Publié: (2021)

Efficacy and tolerability of chemotherapy in Chinese patients with AIDS-related Burkitt lymphoma and diffuse large B-cell lymphoma: An observational study
par: Jiang Xiao, et autres
Publié: (2017)

PKCα diffusion and translocation are independent of an intact cytoskeleton
par: Xin Hui, et autres
Publié: (2017)

Immunotherapy for Diffuse Large B-Cell Lymphoma: Current Landscape and Future Directions
par: Dipenkumar Modi, et autres
Publié: (2021)

Stem cell characteristics promote aggressiveness of diffuse large B-cell lymphoma
par: Kung-Chao Chang, et autres
Publié: (2020)

Computed tomography may detect liver infiltration of canine diffuse hepatic lymphoma
par: Toshiyuki Tanaka, et autres
Publié: (2021)

Epigenetic silencing of TFPI-2 in canine diffuse large B-cell lymphoma.
par: Serena Ferraresso, et autres
Publié: (2014)

Poor oral function is associated with loss of independence or death in functionally independent older adults.
par: Yusuke Nagamine, et autres
Publié: (2021)

The Dark Side of Pyroptosis of Diffuse Large B-Cell Lymphoma in B-Cell Non-Hodgkin Lymphoma: Mediating the Specific Inflammatory Microenvironment
par: Wei Wang, et autres
Publié: (2021)

Dynamin inhibition causes context-dependent cell death of leukemia and lymphoma cells.
par: Christopher von Beek, et autres
Publié: (2021)

Amplitude death and restoration in networks of oscillators with random-walk diffusion
par: Pau Clusella, et autres
Publié: (2021)

Explosive death induced by mean–field diffusion in identical oscillators
par: Umesh Kumar Verma, et autres
Publié: (2017)

Multiple Diffuse Coding Metasurface of Independent Polarization for RCS Reduction
par: Xinmin Han, et autres
Publié: (2020)

Genome-wide discovery of somatic regulatory variants in diffuse large B-cell lymphoma
par: Sarah E. Arthur, et autres
Publié: (2018)

Diffuse large B-cell lymphoma of the pterygopalatine fossa with multiple cranial nerve palsies
par: Shota Ida, et autres
Publié: (2021)

Treatment strategies for patients with diffuse large B-cell lymphoma: past, present, and future
par: Flowers CR, et autres
Publié: (2012)

STAT3-coordinated migration facilitates the dissemination of diffuse large B-cell lymphomas
par: Yi-Ru Pan, et autres
Publié: (2018)

Absolute monocyte count as a prognostic parameter in diffuse large B cell lymphoma
par: IRIGOÍN,VICTORIA, et autres
Publié: (2019)

Detection and Clinical Significance of Thrombus Molecular Markers in Diffuse Large B-cell Lymphoma
par: WANG Yuhong, et autres
Publié: (2021)

Harnessing the immune system through programmed death-1 blockade in the management of Hodgkin lymphoma
par: Oncale MB, et autres
Publié: (2017)

Reovirus Activates a Caspase-Independent Cell Death Pathway
par: Angela K. Berger, et autres
Publié: (2013)

Epstein-Barr virus-induced gene 3 (EBI3): a novel diagnosis marker in Burkitt lymphoma and diffuse large B-cell lymphoma.
par: Julie Gonin, et autres
Publié: (2011)

Proposal and validation of a method to classify genetic subtypes of diffuse large B cell lymphoma
par: Lucía Pedrosa, et autres
Publié: (2021)

Importance of diagnosis-to-treatment interval in newly diagnosed patients with diffuse large B-cell lymphoma
par: Masahiro Yoshida, et autres
Publié: (2021)

Case of primary diffuse large B-cell lymphoma of lacrimal sac in a Japanese patient
par: Fusae Kajita, et autres
Publié: (2010)

Primary diffuse large B-cell lymphoma of the prostate: a case report and review of the literature
par: Mengwei Ren, et autres
Publié: (2021)

Predictors for bronchoalveolar lavage recovery failure in diffuse parenchymal lung disease
par: Keigo Koda, et autres
Publié: (2021)

Ran GTPase-activating protein 1 is a therapeutic target in diffuse large B-cell lymphoma.
par: Kung-Chao Chang, et autres
Publié: (2013)

JAM-A overexpression is related to disease progression in diffuse large B-cell lymphoma and downregulated by lenalidomide
par: Peng-Peng Xu, et autres
Publié: (2017)

DIFFUSE large B cell lymphoma presenting with near total occlusion of pulmonary artery due to thrombus
par: Jaideep Das Gupta, et autres
Publié: (2021)

Primary non-metastatic extra-nodal diffuse large B-cell lymphoma of the prostate and seminal vesicle
par: Frances Harley, et autres
Publié: (2022)

A CASE OF STAGE 1E DIFFUSE LARGE B-CELL LYMPHOMA PRESENTED WITH KNEE INVOLVEMENT
par: Mesut Tığlıoğlu, et autres
Publié: (2021)

Infliximab induces clonal expansion of γδ-T cells in Crohn's disease: a predictor of lymphoma risk?
par: Jens Kelsen, et autres
Publié: (2011)

Waist to height ratio is an independent predictor for the incidence of chronic kidney disease.
par: Keiichi Odagiri, et autres
Publié: (2014)

Several frailty parameters highly prevalent in middle age (50–65) are independent predictors of adverse events
par: Lauriane Segaux, et autres
Publié: (2021)

Cytopenias After CD19 Chimeric Antigen Receptor T-Cells (CAR-T) Therapy for Diffuse Large B-Cell Lymphomas or Transformed Follicular Lymphoma: A Single Institution Experience
par: Schaefer A, et autres
Publié: (2021)

Specific Cytotoxic Effect of an Auristatin Nanoconjugate Towards CXCR4+ Diffuse Large B-Cell Lymphoma Cells
par: Falgàs A, et autres
Publié: (2021)